4
Shared Docs
4
Same-Page
4 / 4
Mentions
ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human
al Management Senior Underwriter and Director of New Markets Joanna Syroka; Environmental Defense Fund Director of Working Lands Maggie Monast; and ClearPath Executive Director Rich Powell; 1:00 PM Cabinet Officers: * Treasury Secretary Mnuchin participates in Independent Community Bankers of America Vir
ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human
tal Management Senior Underwriter and Director of New Markets Joanna Syroka; Environmental Defense Fund Director of Working Lands Maggie Monast; and ClearPath Executive Director Rich Powell; 1:00 PM Cabinet Officers: • Treasury Secretary Mnuchin participates in Independent Community Bankers of America Vi
ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human
al Management Senior Underwriter and Director of New Markets Joanna Syroka; Environmental Defense Fund Director of Working Lands Maggie Monast; and ClearPath Executive Director Rich Powell; 1:00 PM Cabinet Officers: EFTA00148937 • Treasury Secretary Mnuchin participates in Independent Community Banker
ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human
enior Underwriter and Director EFTA01658536 of New Markets Joanna Syroka; Environmental Defense Fund Director of Working Lands Maggie Monast; and ClearPath Executive Director Rich Powell; 1:00 PM Cabinet Officers: • Treasury Secretary Mnuchin participates in Independent Community Bankers of America V
Entities connected to both Amgen and ClearPath

Jeffrey Epstein
PERSON
Donald Trump
PERSON
Michael Jackson
PERSON
United States
LOCATION
Philadelphia
LOCATION
Stephen Hawking
PERSON
Julie K. Brown
PERSON
George Mitchell
PERSON
Bill Clinton
PERSON
Barack Obama
PERSON
Marc Rich
PERSON
Joe Biden
PERSON
Prince Andrew
PERSON
Michael Cohen
PERSON
Hillary Clinton
PERSON
John Brennan
PERSON
Houston
LOCATION
Lawrence Krauss
PERSON
Milwaukee
LOCATION
Justin Trudeau
PERSON